|
US4018799A
(en)
|
1973-11-19 |
1977-04-19 |
Hoffmann-La Roche Inc. |
Antioxidant chroman compounds
|
|
US4026907A
(en)
|
1973-11-19 |
1977-05-31 |
Hoffmann-La Roche Inc. |
Antioxidant chroman compounds
|
|
JPS5640651A
(en)
|
1979-09-12 |
1981-04-16 |
Takeda Chem Ind Ltd |
Quinone compound and its preparation
|
|
US5272180A
(en)
|
1987-07-29 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Cell proliferation inhibitor
|
|
US5348973A
(en)
|
1990-10-09 |
1994-09-20 |
Rhone-Poulenc Chimie |
Resolution of hydroxychroman-2-carboxylic acid esters by enantiomeric hydrolysis
|
|
US6150402A
(en)
|
1994-08-15 |
2000-11-21 |
Loma Linda University Medical Center |
Natriuretic compounds
|
|
HU226208B1
(en)
|
1994-12-28 |
2008-06-30 |
Janssen Pharmaceutica Nv |
Use of nebivolol for producing anti-atherogenic pharmaceuticals
|
|
WO1997007109A1
(en)
|
1995-08-21 |
1997-02-27 |
Takeda Chemical Industries, Ltd. |
Quinone compound, its production and use
|
|
US6232060B1
(en)
|
1996-01-19 |
2001-05-15 |
Galileo Laboratories, Inc. |
Assay system for anti-stress agents
|
|
US5801159A
(en)
|
1996-02-23 |
1998-09-01 |
Galileo Laboratories, Inc. |
Method and composition for inhibiting cellular irreversible changes due to stress
|
|
DE69712888D1
(de)
|
1996-07-11 |
2002-07-04 |
Takeda Chemical Industries Ltd |
ZUSAMMENSTELLUNGEN DIE beta-AMYLOID PROTEIN BEDINGTE ZYTOTOXIZITÄT VERHINDERN
|
|
JP3093170B2
(ja)
|
1996-09-19 |
2000-10-03 |
株式会社ジャパンエナジー |
ヒドロキノン誘導体及びその医薬用途
|
|
US5821247A
(en)
|
1996-09-19 |
1998-10-13 |
Japan Energy Corporation |
Hydroquinone derivative and pharmaceutical use thereof
|
|
JP3913329B2
(ja)
|
1997-09-11 |
2007-05-09 |
株式会社クラレ |
(±)−クロマンカルボン酸の光学分割法
|
|
FR2783519B1
(fr)
|
1998-09-23 |
2003-01-24 |
Sod Conseils Rech Applic |
Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
|
|
WO2000078296A2
(en)
|
1999-06-17 |
2000-12-28 |
Basf Aktiengesellschaft |
Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
|
|
US6426362B1
(en)
|
1999-10-08 |
2002-07-30 |
Galileo Laboratories, Inc. |
Formulations of tocopherols and methods of making and using them
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
WO2002012221A1
(en)
|
2000-08-03 |
2002-02-14 |
Kuraray Co., Ltd. |
Method for optical resolution of (±)-6-hydroxy-2,5,7,8-tetramethylcoumarone-2-carboxylic acid
|
|
US7034054B2
(en)
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
|
US20020132845A1
(en)
|
2000-12-15 |
2002-09-19 |
Miller Guy Michael |
Compositions and methods for the prevention and treatment of tissue ischemia
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
NZ513547A
(en)
|
2001-08-13 |
2002-09-27 |
Antipodean Biotechnology Ltd |
Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
|
|
AU2002327517B2
(en)
|
2001-08-21 |
2008-04-17 |
Johnson & Johnson Consumer Companies, Inc. |
Tocopherol enriched compositions and amelioration of inflammatory symptoms
|
|
US20030144219A1
(en)
|
2001-11-15 |
2003-07-31 |
Phinney Stephen Dodge |
Formulations and methods for treatment or amelioration of inflammatory conditions
|
|
US6667330B2
(en)
|
2002-01-31 |
2003-12-23 |
Galileo Pharmaceuticals, Inc. |
Furanone derivatives
|
|
US7078541B2
(en)
|
2002-02-07 |
2006-07-18 |
Galileo Pharmaceuticals, Inc. |
Benzofuran derivatives
|
|
US6653346B1
(en)
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
|
GB0204232D0
(en)
|
2002-02-22 |
2002-04-10 |
Isis Innovation |
Assay
|
|
DE60211875T2
(de)
|
2002-07-01 |
2006-10-26 |
Santhera Pharmaceuticals (Schweiz) Ag |
Screeningverfahren und Verbindungen zur Behandlung von Friedreich ataxia
|
|
JP4599292B2
(ja)
|
2002-10-30 |
2010-12-15 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
物理的−化学的特性に基づく治療用化合物の同定
|
|
EP1454627A1
(en)
|
2003-03-06 |
2004-09-08 |
MyoContract Ltd. |
Alpha-Keto carbonyl calpain inhibitors
|
|
WO2005033092A1
(en)
|
2003-09-19 |
2005-04-14 |
Galileo Pharmaceuticals, Inc. |
Chroman derivatives
|
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
FR2875803B1
(fr)
|
2004-09-24 |
2006-11-24 |
Catalys Sarl |
Preparation de composes phenol-amides a proprietes antioxydantes
|
|
EA035619B1
(ru)
|
2005-06-01 |
2020-07-16 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Композиции для использования в способе лечения митохондриальных нарушений
|
|
JP2009508867A
(ja)
|
2005-09-15 |
2009-03-05 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
|
|
WO2007095630A2
(en)
|
2006-02-15 |
2007-08-23 |
The Regents Of The University Of California |
New ubiquinone analogs and methods of use
|
|
EP1986636B1
(en)
|
2006-02-22 |
2013-04-24 |
Edison Pharmaceuticals, Inc. |
Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
|
|
ATE539071T1
(de)
*
|
2006-10-26 |
2012-01-15 |
Mitsubishi Gas Chemical Co |
Verfahren zur herstellung von s-(-)-6-hydroxy-2,5,7,8-tetramethylchroman-2-ca bonsäure
|
|
WO2008086025A2
(en)
|
2007-01-10 |
2008-07-17 |
Edison Pharmaceuticals, Inc. |
Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
|
|
PL2220030T3
(pl)
*
|
2007-11-06 |
2016-07-29 |
Bioelectron Tech Corp |
Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
|
|
WO2009088572A2
(en)
|
2008-01-07 |
2009-07-16 |
Centocor, Inc. |
Method of treating erythropoietin hyporesponsive anemias
|
|
EP2237664A4
(en)
|
2008-01-08 |
2013-05-22 |
Edison Pharmaceuticals Inc |
(HET) ARYL-p-CHINONE DERIVATIVES FOR THE TREATMENT OF OCHONDRIAL DISEASES
|
|
WO2009111576A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
|
|
EP2262519A4
(en)
*
|
2008-03-05 |
2011-03-23 |
Edison Pharmaceuticals Inc |
TREATMENT OF HEARING AND BALANCING DISORDERS WITH REDOXACTIVE THERAPEUTICS
|
|
EP2310038A4
(en)
|
2008-05-15 |
2012-03-14 |
Edison Pharmaceuticals Inc |
TREATMENT OF HEARING AND BALANCE OF IMPROVENCE WITH COMPOUNDS WITH ERYTHROPOETIN EFFECT
|
|
WO2009143268A2
(en)
|
2008-05-22 |
2009-11-26 |
Edison Pharmaceuticals, Inc. |
Treatment of mitochondrial diseases with an erythropoietin mimetic
|
|
JP5266875B2
(ja)
|
2008-05-23 |
2013-08-21 |
三菱瓦斯化学株式会社 |
有機カルボン酸エステルからの光学活性有機カルボン酸の製造方法
|
|
EP2303824B1
(en)
|
2008-06-25 |
2015-03-25 |
Edison Pharmaceuticals, Inc. |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
|
|
WO2010005989A1
(en)
|
2008-07-09 |
2010-01-14 |
Edison Pharmaceuticals, Inc. |
Dermatological compositions with anti-aging and skin even-toning properties
|
|
US20100029784A1
(en)
|
2008-07-30 |
2010-02-04 |
Hinman Andrew W |
Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
|
|
WO2010014758A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Pharmaceuticals, Inc. |
Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
|
|
EP2344142B1
(en)
|
2008-09-10 |
2024-06-26 |
PTC Therapeutics, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
|
CA2740773A1
(en)
|
2008-10-14 |
2010-04-22 |
Edison Pharmaceuticals, Inc. |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
|
WO2010051277A1
(en)
|
2008-10-28 |
2010-05-06 |
Edison Pharmaceuticals, Inc. |
Process for the production of alpha-tocotrienol and derivatives
|
|
EA201101576A1
(ru)
|
2009-04-28 |
2012-04-30 |
Эдисон Фармасьютикалз, Инк. |
Лекарственная форма токотриенол хинонов для лечения офтальмических (глазных) заболеваний
|
|
WO2010126910A1
(en)
|
2009-04-28 |
2010-11-04 |
Edison Pharmaceuticals, Inc. |
Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
|
|
CA2777479C
(en)
|
2009-04-28 |
2017-10-17 |
Ptc Therapeutics, Inc. |
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
|
|
JP2012531411A
(ja)
|
2009-06-25 |
2012-12-10 |
アンペア ライフ サイエンシーズ,インコーポレイテッド |
トコトリエノールまたはトコトリエノール濃縮抽出物を用いた広汎性発達障害の処置
|
|
NO2470168T3
(cg-RX-API-DMAC7.html)
|
2009-08-26 |
2018-06-30 |
|
|
|
WO2011041452A2
(en)
|
2009-10-01 |
2011-04-07 |
Ampere Life Sciences, Inc. |
Mouse model for identifying compounds for the treatment of oxidative stress
|
|
CA2797644A1
(en)
|
2009-12-31 |
2011-07-07 |
Edison Pharmaceuticals, Inc. |
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
|
|
US8464722B2
(en)
|
2010-03-04 |
2013-06-18 |
Medline Industries, Inc. |
Folded telescopic equipment drape and method of folding and using the same
|
|
EA201201268A1
(ru)
|
2010-03-09 |
2013-04-30 |
Эдисон Фармасьютикалз, Инк. |
Синтез производных альфа-токоферолхинона и способы их применения
|
|
WO2011113018A1
(en)
|
2010-03-12 |
2011-09-15 |
Ampere Life Sciences, Inc. |
Measurement and control of biological time
|
|
EA201201374A1
(ru)
|
2010-04-06 |
2013-04-30 |
Эдисон Фармасьютикалз, Инк. |
Лечение атаксии-телеангиэктазии
|
|
AU2011245384C1
(en)
|
2010-04-27 |
2016-09-01 |
Bioelectron Technology Corporation |
Formulations of quinones for the treatment of ophthalmic diseases
|
|
WO2012009271A1
(en)
|
2010-07-14 |
2012-01-19 |
Penwest Pharmaceuticals Co. |
Methods of providing anticoagulation effects in subjects
|
|
US20130345312A1
(en)
|
2010-08-06 |
2013-12-26 |
Orion D. Jankowski |
Treatment of mitochondrial diseases with naphthoquinones
|
|
WO2012019032A1
(en)
|
2010-08-06 |
2012-02-09 |
Ampere Life Sciences, Inc. |
Treatment of mitochondrial diseases with vitamin k
|
|
WO2012068552A1
(en)
|
2010-11-19 |
2012-05-24 |
Edison Pharmaceuticals, Inc. |
Methods for improving blood glucose control
|
|
WO2012154613A1
(en)
|
2011-05-06 |
2012-11-15 |
Edison Pharmaceuticals, Inc. |
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
US9464016B2
(en)
|
2011-06-14 |
2016-10-11 |
Edison Pharmaceuticals, Inc. |
Catechol derivatives for treatment of oxidative stress diseases
|
|
WO2013006736A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc |
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
|
|
ES2795798T3
(es)
|
2011-07-06 |
2020-11-24 |
Ptc Therapeutics Inc |
Tratamiento de aciduria metilmalónica, aciduria isovalérica, y otras acidurias orgánicas con tocotrienol quinonas
|
|
CA2842486C
(en)
|
2011-07-19 |
2022-09-06 |
Edison Pharmaceuticals, Inc. |
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
|
|
CA2883879A1
(en)
|
2012-09-07 |
2014-03-13 |
Edison Pharmaceuticals, Inc. |
Quinone derivatives for use in the modulation of redox status of individuals
|
|
MX355430B
(es)
|
2013-03-08 |
2018-04-18 |
Unilever Nv |
Compuestos de resorcinol para uso dermatologico.
|
|
JP2016515526A
(ja)
|
2013-03-15 |
2016-05-30 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
酸化ストレス障害の処置のためのアルキル−ヘテロアリール置換されたキノン誘導体
|
|
US20140275045A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
WO2014194292A1
(en)
|
2013-05-31 |
2014-12-04 |
Edison Pharmaceuticals, Inc. |
Carboxylic acid derivatives for treatment of oxidative stress disorders
|
|
EP3233819A1
(en)
|
2014-12-16 |
2017-10-25 |
Bioelectron Technology Corporation |
Methods for chiral resolution of trolox
|
|
HUE058877T2
(hu)
|
2014-12-16 |
2022-09-28 |
Ptc Therapeutics Inc |
(R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai
|
|
JP2018502127A
(ja)
|
2015-01-12 |
2018-01-25 |
バイオエレクトロン テクノロジー コーポレイション |
放射線被曝に対する防護のためのキノン
|
|
JP7117241B2
(ja)
|
2015-12-16 |
2022-08-12 |
ピーティーシー セラピューティクス, インコーポレイテッド |
混合されたトコール組成物からアルファ-トコトリエノールを富化するための改良された方法
|
|
EP3389646A1
(en)
|
2015-12-17 |
2018-10-24 |
BioElectron Technology Corporation |
Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
|
WO2017123823A1
(en)
|
2016-01-12 |
2017-07-20 |
Bioelectron Technology Corporation |
Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
|
|
CA3011293A1
(en)
|
2016-01-12 |
2017-07-20 |
Ptc Therapeutics, Inc. |
Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels
|
|
US20190241497A1
(en)
|
2016-10-28 |
2019-08-08 |
Andrew W. Hinman |
Methods for analyzing p-hydroquinone levels and ratios
|
|
JP2018083799A
(ja)
|
2016-11-15 |
2018-05-31 |
バイオエレクトロン テクノロジー コーポレイション |
2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩
|
|
WO2018093957A1
(en)
|
2016-11-15 |
2018-05-24 |
Bioelectron Technology Corporation |
2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
|
|
WO2018129411A1
(en)
|
2017-01-06 |
2018-07-12 |
Bioelectron Technology Corporation |
Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
|
|
WO2018191732A1
(en)
|
2017-04-14 |
2018-10-18 |
Bioelectron Technology Corporation |
Methods and compositions for treatment of inflammation and oxidative stress
|
|
US20180333389A1
(en)
|
2017-04-14 |
2018-11-22 |
Bioelectron Technology Corporation |
Vitamin e compositions and methods of use therefor
|